REVEAL Registry: Impact of Clinical Worsening on Three-Year Outcomes in Pulmonary Arterial Hypertension

Adaani Frost,David B Badesch,Dave P Miller,Raymond L Benza,Michael D Mcgoon

Chest（2010）

引用 1|浏览5

暂无评分

摘要

PURPOSE: The Registry to EValuate Early And Long-term Pulmonary Arterial Hypertension (PAH) Disease Management (REVEAL) is a 54-center, observational, US-based study that providing information about demographics, course and management of patients with Group I PAH. Three year outcomes from time of REVEAL enrollment and 2-year major event-free survival from time of clinical worsening are presented.

查看译文

关键词

pulmonary arterial hypertension,arterial hypertension,clinical worsening,three-year

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要